Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Additionally, Recursion Pharmaceuticals plans to present updated clinical data from the TUPELO trial in a webinar scheduled for December 8, 2025. The webinar will provide more insights into the safety ...

We've now combed through hundreds of thousands of files, photos and videos. They stretch back decades but their effect has been immediate. All week we have said that being mentioned in the files is ...

Andrew Beattie was part of the original editorial team at Investopedia and has spent twenty years writing on a diverse range of financial topics including business, investing, personal finance, and ...

Are President Donald Trump’s policies bringing down grocery bills? Grocery prices have been on the rise for most of the past six years, as supply chain bottlenecks, the war in Ukraine and excessive ...